Drug Discovery and Development Analysis & Statistics, July 2014 (p50)

24/7 Customer Support

Talk to Louis

+44 20 3286 0679

All regions

1471-1500 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Beta-2 Receptors  Antagonists -Pipeline Insights, 2014

Beta-2 Receptors Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Beta-2 Receptors Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors -Pipeline Insights, 2014

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors -Pipeline Insights, 2014

Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Diglyceride Acyltransferase 1 (DGAT-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Endothelin Receptor A (ETA) Antagonists -Pipeline Insights, 2014

Endothelin Receptor A (ETA) Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Receptor A (ETA) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Endothelin Receptor B (ETB) Antagonists -Pipeline Insights, 2014

Endothelin Receptor B (ETB) Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Receptor B (ETB) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
GABA Receptor Agonists -Pipeline Insights, 2014

GABA Receptor Agonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
GABA Receptor Antagonists -Pipeline Insights, 2014

GABA Receptor Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
GABA Receptor Modulators -Pipeline Insights, 2014

GABA Receptor Modulators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Receptor Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
GABA Transaminase Inhibitors -Pipeline Insights, 2014

GABA Transaminase Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABA Transaminase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
GABAA Agonists -Pipeline Insights, 2014

GABAA Agonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAA Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAA Modulators -Pipeline Insights, 2014

GABAA Modulators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAA Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAB Agonists -Pipeline Insights, 2014

GABAB Agonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAB Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
GABAB Modulators -Pipeline Insights, 2014

GABAB Modulators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GABAB Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Gamma Secretase inhibitors -Pipeline Insights, 2014

Gamma Secretase inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Gamma Secretase inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ganglioside GD2 Inhibitors -Pipeline Insights, 2014

Ganglioside GD2 Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ganglioside GD2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ganglioside GD3 Inhibitors -Pipeline Insights, 2014

Ganglioside GD3 Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ganglioside GD3 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ghrelin Receptor Agonists -Pipeline Insights, 2014

Ghrelin Receptor Agonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ghrelin Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Ghrelin Receptor Antagonists -Pipeline Insights, 2014

Ghrelin Receptor Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ghrelin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Glial-Derived Neurotrophic Factor (GDNF) Modulators -Pipeline Insights, 2014

Glial-Derived Neurotrophic Factor (GDNF) Modulators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glial-Derived Neurotrophic Factor (GDNF) Modulators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Glucokinase Activators -Pipeline Insights, 2014

Glucokinase Activators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucokinase Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Glucosylceramide Synthase Inhibitors -Pipeline Insights, 2014

Glucosylceramide Synthase Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucosylceramide Synthase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Glutamate Receptor Antagonists -Pipeline Insights, 2014

Glutamate Receptor Antagonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glutamate Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Glycan Inhibitors -Pipeline Insights, 2014

Glycan Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glycan Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2014

Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glycine Reuptake Inhibitors (GlyRI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Glycogen Synthase Kinase 3 (GSK-3) Inhibitors -Pipeline Insights, 2014

Glycogen Synthase Kinase 3 (GSK-3) Inhibitors -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glycogen Synthase Kinase 3 (GSK-3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
Group II Metabotropic Glutamate Receptor Agonists -Pipeline Insights, 2014

Group II Metabotropic Glutamate Receptor Agonists -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Group II Metabotropic Glutamate Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators -Pipeline Insights, 2014

Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Guanylate Cyclase-Coupled Receptor Activators -Pipeline Insights, 2014

Guanylate Cyclase-Coupled Receptor Activators -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Guanylate Cyclase-Coupled Receptor Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
H 2 Antagonist -Pipeline Insights, 2014

H 2 Antagonist -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“H 2 Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
H 3 Antagonist -Pipeline Insights, 2014

H 3 Antagonist -Pipeline Insights, 2014

  • £ 800
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“H 3 Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development

94 Companies

Read our Company Profiles

AstraZeneca PLC

United Kingdom

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.